3 -amino-imidazo[1, 2-A]pyridine derivatives as SGLT inhibitors

Details for Australian Patent Application No. 2007263391 (hide)

Owner Merck Patent GmbH

Inventors Cezanne, Bertram; Klein, Markus; Mederski, Werner; Tsaklakidis, Christos; Beier, Norbert; Gericke, Rolf

Agent Davies Collison Cave

Pub. Number AU-B-2007263391

PCT Pub. Number WO2007/147478

Priority 10 2006 028 862.9 23.06.06 DE

Filing date 25 May 2007

Wipo publication date 27 December 2007

Acceptance publication date 17 May 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

19 February 2009 PCT application entered the National Phase

  PCT publication WO2007/147478 Priority application(s): WO2007/147478

17 May 2012 Application Accepted

  Published as AU-B-2007263391

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263393-Polymorphic forms and process

2007263387-Method for reconditioning a used grinding roll